On May 22, 2013, we reiterated DexCom, Inc. (DXCM) at Neutral based on its first quarter 2013 earnings results.
On May 1, DexCom announced results for the reported quarter. The company incurred...(read more
DXCM was not on any of my watch lists and does not have a compelling chart, but for some reason I had a nagging feeling all day that I missed something here. This had a pretty good run in price relative in May, but...(read more
DexCom (DXCM), a prominent player in the glucose monitoring market, reported first-quarter fiscal 2011 loss per share of 19 cents, a penny higher than the Zacks Consensus Estimate while...(read more